Bmy stock forecast 2025 bMY’s 2025 growth outlook remains

BMY’s 2025 growth outlook remains linked to cell therapy adoption rates, which market models suggest could accelerate topline figures faster than consensus projections. A pharmacy shelves stocked with pharmaceutical drugs awaiting distribution. Here’s a breakdown of recent trading of $BMY stock by insiders over the last 6 months: Institutional analyst calls for BMY stock forecast 2025 focus on capital allocation discipline, with $4B earmarked for share repurchases, aiding EPS accretion.